MedPath

A randomized controlled trial for Zhongfeng Xingnaoyie decoction in the treatment of Acute Cerebral Infarctio

Phase 1
Recruiting
Conditions
Cerebral Infarction
Registration Number
ITMCTR2100004506
Lead Sponsor
Hospital of Chengdu University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Age between 40-80 years old;
2. Meet the diagnostic criteria for acute cerebral infarction.
3. Onset time of acute cerebral infarction is less than 7 days.
4. NIHSS score >= 6 points.
5. The family members or I signed the written informed consent to participate in this trial.
Those who meet the above 5 items can be included in the study.

Exclusion Criteria

1. It is confirmed by examination that cerebral infarction is caused by brain tumors and vascular malformations;
2. Patients with thrombolysis and emergency interventional thrombolysis and thrombectomy;
3. Patients who died within 24 hours of admission;
4. Accompanied by severe heart disease, cardiac insufficiency, liver dysfunction, renal insufficiency, respiratory failure, malignant tumor, gastrointestinal bleeding, etc.;
5. Mentally ill patients;
6. Those who are participating in other clinical trials.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ational Institute of Health stroke scale;
Secondary Outcome Measures
NameTimeMethod
modified Rankin scale ; the Barthelindex of ADL ;Glasgow Score;
© Copyright 2025. All Rights Reserved by MedPath